Why Kosmos Energy Stock Rallied Over 10% Today
Shares of the offshore energy company took off after it quickly found some cash to fund an acquisition.
Mindfully Curated
Shares of the offshore energy company took off after it quickly found some cash to fund an acquisition.
The FDA is reportedly delaying a decision on authorizing Moderna’s vaccine in adolescents.
China’s political leadership and state-run media appear to be warning investors as well as the public that more restrictions and regulations are on the way.
We are joined on the FYI podcast by Dr. Scott Gottlieb to reflect on the American response to the pandemic.
The retailer is selling some hypermarkets — and getting a lot of cash for them.
The content delivery specialist got some positive attention from a Wall Street analyst firm this morning.
The company just received competency status from one of its largest partners.
BMI earnings call for the period ending September 30, 2021.
This isn’t how earnings beats usually work.
The name of the game is now software as much as it is Nvidia’s leading hardware.
An analyst calls 23andMe’s 11 million sample database unique and unprecedented.
Bacteria can store extra resources for the lean times. It’s a bit like keeping a piggy bank or carrying a backup battery pack. One important reserve is known as cyanophycin granules, which were first noticed by an Italian scientist about 150 years ago….
Researchers have identified a protein that plays a key role in how the brain regulates appetite and metabolism. Loss of the protein, XRN1, from the forebrain, resulted in obese mice with an insatiable appetite, according to a new study.
High energy costs and lower interest rates are helping solar stocks today.
TFC earnings call for the period ending September 30, 2021.
The bank saw shares dip yesterday after reporting earnings, but had a nice recovery today.
The company has completed one phase of an expansion that will allow it to more than double capacity.
SXT earnings call for the period ending September 30, 2021.
Rising from “negative” sales today, Plug predicts $3 billion in 2025 revenue.
The drugmaker is being sued by Relief Therapeutics.